US Patent

US9670147 — Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17

Composition of Matter · Assigned to Reata Pharmaceuticals Inc · Expires 2029-04-20 · 3y remaining

Vulnerability score 25/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects novel oleanolic acid derivatives, including their pharmaceutical compositions and methods of use, invented by Reata Pharmaceuticals Inc.

USPTO Abstract

This invention provides, but is not limited to, novel oleanolic acid derivatives having the formula: wherein the variables are defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds, methods and intermediates useful for making the compounds, and methods of using the compounds and compositions.

Drugs covered by this patent

Patent Metadata

Patent number
US9670147
Jurisdiction
US
Classification
Composition of Matter
Expires
2029-04-20
Drug substance claim
Yes
Drug product claim
No
Assignee
Reata Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.